The total value of China's innovative drug out-licensing deals exceeded $100 billion in the first half of the year, reaching a record high, the Ministry of Industry and Information Technology said on Monday.

Home-grown therapies account for 80 per cent of approvals in first six months of the year.

The total value of China's innovative drug out-licensing deals exceeded $100 billion in the first half of the year, reaching a record high, the Ministry of Industry and…